Oligomers of the Prion Protein Fragment 106−126 Are Likely Assembled from β-Hairpins in Solution, and Methionine Oxidation Inhibits Assembly without Altering the Peptide’s Monomeric Conformation

2010 ◽  
Vol 132 (2) ◽  
pp. 532-539 ◽  
Author(s):  
Megan Grabenauer ◽  
Chun Wu ◽  
Patricia Soto ◽  
Joan-Emma Shea ◽  
Michael T. Bowers
Author(s):  
Ying Zhai ◽  
Na Li ◽  
Dachuan Zhang ◽  
Qi Li ◽  
Guoping Zhou ◽  
...  

2020 ◽  
Vol 21 (19) ◽  
pp. 7410
Author(s):  
Tomas Sneideris ◽  
Mantas Ziaunys ◽  
Brett K.-Y. Chu ◽  
Rita P.-Y. Chen ◽  
Vytautas Smirnovas

Prion protein amyloid aggregates are associated with infectious neurodegenerative diseases, known as transmissible spongiform encephalopathies. Self-replication of amyloid structures by refolding of native protein molecules is the probable mechanism of disease transmission. Amyloid fibril formation and self-replication can be affected by many different factors, including other amyloid proteins and peptides. Mouse prion protein fragments 107-143 (PrP(107-143)) and 89-230 (PrP(89-230)) can form amyloid fibrils. β-sheet core in PrP(89-230) amyloid fibrils is limited to residues ∼160–220 with unstructured N-terminus. We employed chemical kinetics tools, atomic force microscopy and Fourier-transform infrared spectroscopy, to investigate the effects of mouse prion protein fragment 107-143 fibrils on the aggregation of PrP(89-230). The data suggest that amyloid aggregates of a short prion-derived peptide are not able to seed PrP(89-230) aggregation; however, they accelerate the self-replication of PrP(89-230) amyloid fibrils. We conclude that PrP(107-143) fibrils could facilitate the self-replication of PrP(89-230) amyloid fibrils in several possible ways, and that this process deserves more attention as it may play an important role in amyloid propagation.


BMC Neurology ◽  
2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Eva Dvorakova ◽  
Tanja Vranac ◽  
Olga Janouskova ◽  
Maja Černilec ◽  
Simon Koren ◽  
...  

2005 ◽  
Vol 109 (4) ◽  
pp. 443-448 ◽  
Author(s):  
Sigrun Roeber ◽  
Bjarne Krebs ◽  
Manuela Neumann ◽  
Otto Windl ◽  
Inga Zerr ◽  
...  

1995 ◽  
Vol 31 ◽  
pp. 218
Author(s):  
L. Cantoni ◽  
M. Rizzardini ◽  
R. Carcano ◽  
M. Salmona ◽  
R. Chiesa ◽  
...  

2018 ◽  
Vol 114 (3) ◽  
pp. 429a
Author(s):  
Maciej B. Gielnik ◽  
Michał Nowakowski ◽  
Aneta Szymańska ◽  
Igor Yu Zhukov ◽  
Wojciech Maria Kwiatek ◽  
...  

1998 ◽  
Vol 335 (2) ◽  
pp. 369-374 ◽  
Author(s):  
Mar PÉREZ ◽  
Francisco WANDOSELL ◽  
Camilo COLAÇO ◽  
Jesús AVILA

Although a number of features distinguish the disease isoform of the prion protein (PrPSc) from its normal cellular counterpart (PrPC) in the transmissible spongiform encephalopathies (TSEs), the neuropathogenesis of these diseases remains an enigma. The amyloid fibrils formed by fragments of human PrP have, however, been shown to be directly neurotoxic in vitro. We show here that sulphated polysaccharides (heparin, keratan and chondroitin) inhibit the neurotoxicity of these amyloid fibrils and this appears to be mediated via inhibition of the polymerization of the PrP peptide into fibrils. This provides a rationale for the therapeutic effects of sulphated polysaccharides and suggests a rapid in vitro functional screen for TSE therapeutics.


1996 ◽  
Vol 30 (1) ◽  
pp. A38
Author(s):  
Müller Weg ◽  
Perovic S ◽  
Pergande G ◽  
Omoto K ◽  
Ushijima H

2011 ◽  
Vol 49 (6) ◽  
pp. 2109-2115 ◽  
Author(s):  
Ilias G. Bouzalas ◽  
Florian Lörtscher ◽  
Chrysostomos I. Dovas ◽  
Anna Oevermann ◽  
Jan P. M. Langeveld ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document